Program: MCDC

Solicitation Number: TBD

Customer: DTRA RD-CBM

Release Date: Q4FY24

Description: The prioritizations on broad-spectrum direct-acting antivirals (nucleoside/nucleotide-like compounds and combination therapies) and host-directed broad-spectrum antivirals and antibacterials such as molecules that target host signaling pathways, are involved in entry and replication, epigenetic modifications in the host, and modulation of host response.

upcoming_solicitations

solicitation_program: MCDC

solicitation_number: TBD

solicitation_customer: DTRA RD-CBM

solicitation_anticipated_release_date: Q4FY24

solicitation_description: The prioritizations on broad-spectrum direct-acting antivirals (nucleoside/nucleotide-like compounds and combination therapies) and host-directed broad-spectrum antivirals and antibacterials such as molecules that target host signaling pathways, are involved in entry and replication, epigenetic modifications in the host, and modulation of host response.

solicitation_url: https://www.medcbrn.org/solicitations/